Phosphodiesterase 4 inhibition in the treatment of psoriasis, psoriatic arthritis and other chronic inflammatory diseases.
about
Association between Psoriasis and Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysisSelective Phosphodiesterase 4B Inhibitors: A ReviewNovel pharmacological approaches for the treatment of acne vulgarisAdvances in targeting cyclic nucleotide phosphodiesterasesCyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.Inhibition of type 4 cyclic nucleotide phosphodiesterase blocks intracellular TLR signaling in chronic lymphocytic leukemia and normal hematopoietic cells.Small Molecules in the Treatment of Psoriasis.Ustekinumab : targeting the IL-17 pathway to improve outcomes in psoriatic arthritis.New treatments for inflammatory rheumatic disease.Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy.Novel risk genes for systemic lupus erythematosus predicted by random forest classificationRoles of roflumilast, a selective phosphodiesterase 4 inhibitor, in airway diseases.New therapeutic solutions for Behçet's syndrome.Crisaborole and its potential role in treating atopic dermatitis: overview of early clinical studies.Phosphodiesterase 4 Inhibitor Therapies for Atopic Dermatitis: Progress and Outlook.Pathogenesis of psoriasis and development of treatment.Sandalwood Album Oil as a Botanical Therapeutic in Dermatology.Successful Treatment of Refractory Type 1 Pityriasis Rubra Pilaris With Apremilast.Hepatoprotective role of vardenafil against experimentally induced hepatitis in mice.East Indian Sandalwood Oil Is a Phosphodiesterase Inhibitor: A New Therapeutic Option in the Treatment of Inflammatory Skin Disease.PDE3A-SLCO1C1locus is associated with response to anti-tumor necrosis factor therapy in psoriatic arthritis
P2860
Q26772143-8034BBD3-C816-4590-B931-E50AEF04F8A1Q28081071-43E5C4A7-D8AE-4F5D-B1BC-1C9EBDED7024Q28241186-019DADA1-259E-415B-BEFF-18527079D1A4Q34139490-7E1F570D-B00B-48D5-B783-1411E1B85117Q34765802-F024DC0D-BBB2-4D67-B5D3-4841BCCFFCACQ35096709-3978BBC9-488D-4390-AC8C-9ACB547E5269Q35740706-0CB3061F-AE51-47C8-94A7-1BC71C1E6EAAQ38189853-40D06809-6B59-4C4F-BB03-6B148E67355FQ38266252-DC5C4E6E-F81F-469E-916E-4905A09313B8Q38273695-07E8EF7E-E7D8-42A1-8C0B-3BEA80AE56DBQ38663531-2E65217E-64C4-48E2-B975-02881CBE0578Q38681962-E411A047-93C6-4DED-8770-70F049A81458Q38830790-53B87E8C-BE21-4A7F-B857-824062738580Q38860798-585153D4-D7BF-4703-832D-A2147258BA5FQ39417376-F5C7B82F-FC9B-4980-8E23-EFCFA8A228A0Q48144635-137FDBDA-139E-4571-91D0-930BC8F3C899Q49209799-A716AF72-4F00-408D-965D-B702B8E84A1FQ50139930-0A344FF5-3648-4BEB-BB04-C5172844ED5DQ51373481-D53E0E3C-0EC3-4031-953A-A44E7CEB7B18Q51733163-D981CD80-E431-4174-80CF-88E534C034FCQ58529418-46413808-BBBF-45CD-84FE-ACD3971D166F
P2860
Phosphodiesterase 4 inhibition in the treatment of psoriasis, psoriatic arthritis and other chronic inflammatory diseases.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Phosphodiesterase 4 inhibition ...... chronic inflammatory diseases.
@en
Phosphodiesterase 4 inhibition ...... chronic inflammatory diseases.
@en-gb
type
label
Phosphodiesterase 4 inhibition ...... chronic inflammatory diseases.
@en
Phosphodiesterase 4 inhibition ...... chronic inflammatory diseases.
@en-gb
prefLabel
Phosphodiesterase 4 inhibition ...... chronic inflammatory diseases.
@en
Phosphodiesterase 4 inhibition ...... chronic inflammatory diseases.
@en-gb
P2860
P1476
Phosphodiesterase 4 inhibition ...... chronic inflammatory diseases.
@en
P2093
Miriam Wittmann
P2860
P2888
P356
10.1007/S13555-013-0023-0
P5530
P577
2013-04-27T00:00:00Z
P5875
P6179
1009419551